Home -> Law Blog Directory -> Personal Injury Law Blogs -> Jacksonville Personal Injury Lawyer
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Personal Injury Law
: Jacksonville Personal Injury LawyerMore Warnings for Derma Fillers
By Eddie Farah
An FDA advisory panel believes the cosmetics industry is not coming clean about the potential adverse side effects from dermal fillers, injected to soften facial wrinkles.
Popular brands are Juvederm (Allergan) and Restylane (Medicis Pharmaceutical Corp).
The experts who make up the panel agreed the labeling should include more serious side effects, how long the product has been on the market, and how long it might take before side effects appear,” says a FDA spokeswoman.
More than 1.5 million of these procedures are done a year, so it's about time. During the last six years, the FDA has received 930 reports of adverse effects from the numerous dermal fillers approved. They include:
· Allergic reactions
· Swelling
· Inflammatory reactions resulting in nodule formation, cold sores, arthritis flare-ups, and other problems
· Infection
· Bruising, bleeding, scars
· Blisters and cysts
· Lumps and bumps
· Numbness, including palsy
· Migration, such as the filler material moving to another site on the face
A number of the reports of adverse events involved injections by untrained personnel, the FDA also found.
No deaths have been reported, but the panel is concerned that the long-term effects of some dermal fillers may not be completely understood.
While the current labels do include several potential adverse effects, they do not always list when the events might occur. The panel is advising the FDA to require manufacturers to note that some events can occur months and sometimes years after injection.
Some plastic surgeons and industry representatives say stronger labels are unnecessary, while other experts welcome the labeling recommendations. #
Originally posted at InjuryBoard by Eddie Farah
Full post as published by Jacksonville Personal Injury Lawyer on November 20, 2008 (boomark / email).
Wrinkle-Fillers
FDA to Review Labeling due to Adverse Event Reports
Acetaminophen
FDA Wants New Safety Warnings
CellCept
Roche Issues Changes to Warnings and Adverse Events
Darvon
Other Propoxyphene-Containing Meds to Require Stronger Warnings
Cipro
The FDA is seeking to add black box warnings of the risk of tendon rupture associated with Cipro and Levaquin.
The ruptures can involve Achilles tendon, shoulder, hand, bicep or thumb tendons, and is especially increased in patients older than 60, or people who have received kidney, heart or lung transplants, as well as people on steroid therapy...

Wrinkle Fillers Linked to Serious Injuries
Concerns About Off-Label Use of Wrinkle Fillers
FDA Panel Recommends Stronger Derma Filler Warnings
Best Old Cigarette Ads and Zoo Warnings
FDA To Review Cosmetic Face Fillers
FDA Adds Additional Black-Box Warnings to Anemia Drugs









